Active substance
Prednicarbate
- US FDA 4
- Health Canada 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PREDNICARBATE | 0.1% | ointment · topical | FOUGERA PHARMS | Prescription | 9 Mar 2007 |
| DERMATOP | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ointment · topical | VALEANT PHARMS NORTH | Discontinued | 23 Sep 1991 |
| DERMATOP E EMOLLIENT | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream · topical | VALEANT BERMUDA | Discontinued | 29 Oct 1993 |
| PREDNICARBATE | 0.1% | cream · topical | FOUGERA PHARMS | Discontinued | 19 Sep 2006 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| DERMATOP EMOLLIENT CREAM | 02230642 | 0.1 % / W/W | CREAM · TOPICAL | BAUSCH HEALTH, CANADA INC. |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.